New Study Shows That When it Comes to Pesticides and Kids, the EPA Has Looked the Other Way
It’s easy to lose count of all of the pesticides that are sprayed on crops in the U.S., and well-nigh impossible to know all of the names (dichloropropene and pyraclostrobin and spinetoram and on and on). But it’s not hard to guess who gets hit hardest by all of these chemicals: kids, whose brain, nervous and hormonal systems are still developing at the time of exposure. What’s more, a new pesticide introduced today will have fewer years to build up in the tissues of, say, a 50-year old, compared to a child who will accumulate a lifetime load of the stuff. That’s the biggest reason that, in 1996, Congress passed and President Bill Clinton signed the Food Quality Protection Act (FQPA). The legislation represented one of the most effective crackdowns on pesticides in the food supply to date, requiring the Environmental Protection Agency not simply to establish a safe threshold of exposure for the population as a whole, but to limit permissible levels much further—10-fold further in fact—to ensure that children are protected too. The legislation benefits everyone of course: Ten times less pyraclostrobin on your apple is a good thing no matter how old you are, but it’s children who are the most important beneficiaries. But a law is only as good as its enforcement and a new study conducted by the Environmental Working Group, —a nonprofit advocacy organization—and published in the journal Environmental Health found that when it...
Publication date: Available online 3 April 2020Source: Best Practice &Research Clinical RheumatologyAuthor(s): Brad T. Tinkle
Publication date: Available online 2 April 2020Source: Best Practice &Research Clinical RheumatologyAuthor(s): George S. Metsios, Rikke H. Moe, George D. Kitas
Publication date: Available online 2 April 2020Source: The Lancet Respiratory MedicineAuthor(s): Alberto L García-Basteiro, Carlos Chaccour, Caterina Guinovart, Anna Llupià, Joe Brew, Antoni Trilla, Antoni Plasencia
Publication date: Available online 3 April 2020Source: Respiratory Medicine Case ReportsAuthor(s): Daniel Franzen, Gilles Straub, Carolin Steinack
Publication date: Available online 3 April 2020Source: Respiratory Medicine Case ReportsAuthor(s): Hoang Bui, Jessica L. Helms, Miguel Sierra-Hoffman, Mark L. Stevens, Rafael Deliz-Aguirre, Miriams T. Castro-Lainez, Rafael J. Deliz
Publication date: Available online 2 April 2020Source: Respiratory Medicine Case ReportsAuthor(s): Caibao Jin, Hui Ren, Yang Hu, Jingyi Wu, Yanping Hu, Zhijun Wang, Youying Wei, Bin Yang, Ling Yang
Publication date: Available online 3 April 2020Source: Heart &LungAuthor(s): Susan J. Pressler, Miyeon Jung, Christopher S. Lee, Thomas P. Arkins, Daniel O'Donnell, Ryan Cook, Giorgos Bakoyannis, Robin Newhouse, Irmina Gradus-Pizlo, Peter S. Pang
Publication date: Available online 2 April 2020Source: Heart &LungAuthor(s): James A. Friedman
Given the current requirements for social distancing as a result of the Covid-19 pandemic, we are now exploring a virtual meeting / webinar on this date.
Authors: Chakrabarti A, Singh S Abstract Introduction: Since the emergence of Candida auris infection in 2009, the disease has been reported from multiple countries within a decade. The infection is classified under urgent threat, as it is multi-drug resistant, causes high mortality, spreads easily in hospital setting and is difficult to identify. Whole-genome sequencing has provided insights into this organisms biology and epidemiology. A comprehensive review of those issues would help the clinicians and scientists facing C. auris infection.Areas covered: We reviewed the epidemiological trends of C. auris infectio...